1. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator. Issue 5 (30th November 2022) Authors: Thuluva, Subhash; Paradkar, Vikram; Matur, Ramesh; Turaga, Kishore; GV, Subba Reddy Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 5(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗